"Psychotropic Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
| Descriptor ID |
D011619
|
| MeSH Number(s) |
D27.505.954.427.700
|
| Concept/Terms |
Psychotropic Drugs- Psychotropic Drugs
- Drugs, Psychotropic
- Psychopharmaceuticals
- Psychoactive Agents
- Agents, Psychoactive
- Psychoactive Drugs
- Drugs, Psychoactive
|
Below are MeSH descriptors whose meaning is more general than "Psychotropic Drugs".
Below are MeSH descriptors whose meaning is more specific than "Psychotropic Drugs".
This graph shows the total number of publications written about "Psychotropic Drugs" by people in this website by year, and whether "Psychotropic Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 |
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 2 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 4 | 5 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 1 | 3 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 3 | 0 | 3 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 0 | 2 |
| 2020 | 4 | 1 | 5 |
| 2021 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Psychotropic Drugs" by people in Profiles.
-
Rothschild AJ. The Pitfalls of Psychotropic Polypharmacy. J Clin Psychopharmacol. 2021 May-Jun 01; 41(3):227-232.
-
McLaren JL, Lichtenstein JD, Metcalfe JD, Charlot LR, Drake RE, Beasley JB. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities. Psychiatr Serv. 2021 09 01; 72(9):988-997.
-
Rothschild AJ, Parikh SV, Hain D, Law R, Thase ME, Dunlop BW, DeBattista C, Conway CR, Forester BP, Shelton RC, Macaluso M, Brown K, Lewis D, Gutin A, Jablonski MR, Greden JF. Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression. Psychiatry Res. 2021 02; 296:113649.
-
Keepers GA, Fochtmann LJ, Anzia JM, Benjamin S, Lyness JM, Mojtabai R, Servis M, Walaszek A, Buckley P, Lenzenweger MF, Young AS, Degenhardt A, Hong SH. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. Am J Psychiatry. 2020 09 01; 177(9):868-872.
-
Chary MA, Manini AF, Boyer EW, Burns M. The Role and Promise of Artificial Intelligence in Medical Toxicology. J Med Toxicol. 2020 10; 16(4):458-464.
-
Keeshin B, Forkey HC, Fouras G, MacMillan HL. Children Exposed to Maltreatment: Assessment and the Role of Psychotropic Medication. Pediatrics. 2020 02; 145(2).
-
McLaurin-Jiang S, Cohen GM, Brown CL, Edwards P, Albertini LW. Integrated Mental Health Training Relates to Pediatric Residents' Confidence with Child Mental Health Disorders. Acad Psychiatry. 2020 Jun; 44(3):299-304.
-
George A, Sturgeon SR, Hankinson SE, Shadyab AH, Wallace RB, Reeves KW. Psychotropic Medication Use and Postmenopausal Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):254-256.
-
Hall RCW, Friedman SH, Sorrentino R, Lapchenko M, Marcus A, Ellis R. The myth of school shooters and psychotropic medications. Behav Sci Law. 2019 Sep; 37(5):540-558.
-
Chiara AN, Kashalikar N, Pomfret TC, Lenz K, Faber DM, Goldstein J, Clements KM, Angelini MC, Leto P, Jeffrey PL. An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid Patients. J Manag Care Spec Pharm. 2018 Aug; 24(8):746-751.